Epidarex Capital is a transatlantic venture capital firm that invests in early-stage, high growth life science and health technology companies in under-ventured research hubs within the UK and US. The firm provides equity capital to start-ups, including university spin-outs, and leverages its deep scientific and industry network to create exceptional value for its portfolio companies and generate strong returns for investors.
Deal activity and portfolio updates would appear here
Connect your data source to see recent transactions